Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas-Reference-Cited by-同舟云学术

Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas

Published:2017-10-03 Issue:53 Volume:8 Page:90706-90718
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ramnefjell Maria¹,Aamelfot Christina²,Helgeland Lars³,Akslen Lars A.¹³

Affiliation:

1. Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, Haukeland University Hospital, University of Bergen, Bergen, Norway

2. Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway

3. Department of Pathology, Haukeland University Hospital, Bergen, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and therapeutic value of human serpin family proteins;Biomedicine & Pharmacotherapy;2024-06

2. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease;Cellular and Molecular Life Sciences;2022-03

3. SERPINB2—its regulation and interplay with aryl hydrocarbon receptor;Journal of Applied Genetics;2021-01-02

4. Deficiency of plasminogen activator inhibitor‐2 results in accelerated tumor growth;Journal of Thrombosis and Haemostasis;2020-10

5. HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, suppresses invasive pseudopodia formation and upregulates plasminogen activator inhibitor-2 in erlotinib-resistant non-small cell lung cancer cells;Acta Pharmacologica Sinica;2020-05-13